File:Pembrolizumab results as in Lung cancer keynote studies KEYNOTE-024 KEYNOTE-042 KEYNOTE-189 KEYNOTE-407.jpg

Page contents not supported in other languages.
This is a file from the Wikimedia Commons
From Wikipedia, the free encyclopedia

Original file ‎(1,020 × 601 pixels, file size: 172 KB, MIME type: image/jpeg)

Summary

Description
English: Pembrolizumab (Pembro) results as in Lung cancer keynote studies compared to chemotherapy KEYNOTE-024 KEYNOTE-042 KEYNOTE-189 KEYNOTE-407
Date
Source

https://doi.org/10.3390/ph13110373 First line Immunotherapy for Non-Small Cell Lung Cancer Nasser NJ, Gorenberg M, Agbarya A.

Pharmaceuticals (Basel). 2020 Nov 8;13(11):373. doi: 10.3390/ph13110373. Figure adapted from this source
Author Nicola J. Nasser, Miguel Gorenberg, Abed Agbarya

Licensing

w:en:Creative Commons
attribution share alike
This file is licensed under the Creative Commons Attribution-Share Alike 4.0 International license.
You are free:
  • to share – to copy, distribute and transmit the work
  • to remix – to adapt the work
Under the following conditions:
  • attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • share alike – If you remix, transform, or build upon the material, you must distribute your contributions under the same or compatible license as the original.

Captions

Pembrolizumab use for treatment of Lung cancer in the first line with or without chemotherapy: keynote studies KEYNOTE-024 KEYNOTE-042 KEYNOTE-189 KEYNOTE-407

Items portrayed in this file

depicts

inception

5 November 2020

media type

image/jpeg

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current02:42, 27 January 2021Thumbnail for version as of 02:42, 27 January 20211,020 × 601 (172 KB)SannecolaUploaded a work by Nicola J. Nasser, Miguel Gorenberg, Abed Agbarya from https://doi.org/10.3390/ph13110373 Markers of Toxicity and Response to Radiation Therapy in Patients With Prostate Cancer. Nasser NJ, Klein J, Agbarya A. Adv Radiat Oncol. 2020 Oct 27;6(1):100603. doi: 10.1016/j.adro.2020.10.016. eCollection 2021 Jan-Feb. PMID: 33490732. Figure adapted from this source with UploadWizard
The following pages on the English Wikipedia use this file (pages on other projects are not listed):

Global file usage

The following other wikis use this file:

Metadata

This file contains additional information, probably added from the digital camera or scanner used to create or digitize it.

If the file has been modified from its original state, some details may not fully reflect the modified file.

Retrieved from "https://en.wikipedia.org/wiki/File:Pembrolizumab_results_as_in_Lung_cancer_keynote_studies_KEYNOTE-024_KEYNOTE-042_KEYNOTE-189_KEYNOTE-407.jpg"